Pharma Excipients

News on Pharma Excipients

Drug-Based Reversal of Drug Resistance in Hepatocellular Carcinoma (HCC) Using TPGS

Abstract Hepatocellular carcinoma (HCC) is a cancer with high incidence and mortality rates worldwide. In the various treatment methods for HCC, the lack of cancer cell specificity and the development of multidrug resistance (MDR) are two major obstacles in the treatment of HCC. P-glycoprotein (P-gp) is an ATP-dependent drug efflux pump that can…

Controlled Release: Timing is Everything

IFF officially release a new Controlled release platform on 15th of May 2024. Here you get a deeper insight in the  "Timing is Everything" platform where you can learn about pharmaceutical formulations to benefit patients and the importance of controlled release of active ingredients. No…
Read More...